Stevens Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Stevens Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-74,761	Closed	-$1.11M	–	1191
2015 Q4	$1.11M	Buy	+74,761	New	+$1.25M	0.04%	394
2014 Q2	–	Sell	-44,510	Closed	-$519K	–	1391
2014 Q1	$519K	Buy	+44,510	New	+$754K	0.01%	651
2013 Q4	–	Sell	-13,074	Closed	-$188K	–	1316
2013 Q3	$188K	Buy	+13,074	New	+$200K	0.01%	922

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stevens Capital Management's MNTA Position: Q1 2016 in Review

Stevens Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2016, closing a stake of 74,761 shares — an estimated $1.11M sold.

Stevens Capital Management first reported a position in MNTA in Q3 2013 and held it in 3 quarters. The position peaked at $1.11M in Q4 2015. 148 funds tracked by Wall St. Rank hold MNTA as of Q1 2016.

Stevens Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Stevens Capital Management sold 74,761 Momenta Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.11M.
Stevens Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
Stevens Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.11M in Q4 2015.
148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2016.

Based on Stevens Capital Management's 13F filing for Q1 2016, filed 13 May 2016.